Louis Plamondon

Louis Plamondon is a recognized leader in the discovery, development, and commercialization of small-molecule drugs. He is a passionate scientist with experience leading multidisciplinary teams and overseeing programs across several therapeutic areas and development stages.

Prior to joining LifeMine, Louis was SVP and Head of CMC at Constellation Pharmaceuticals (a MorphoSys company) where he led all pre-development/development activities including the production of Drug Substance and Drug Products for pre-clinical studies, toxicology studies, clinical studies, and preparations for commercialization.

Louis earned his Ph.D. in Organic Chemistry from the Université de Montréal under the guidance of James D. Wuest and completed his postdoctoral fellowship at Harvard University under the guidance of Stuart L. Schreiber.